STAT

NOVEMBER 11, 2024

23andMe, the genetics startup that has repeatedly captured the public imagination and then faced nearly fatal business challenges, announced Monday that it would halt its efforts to develop new medicines and lay off 40% of its workforce, focusing instead on selling genetic tests to consumers and using the resulting data for research. In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — that it could use the genetic da

363

363

PharmaVoice

NOVEMBER 11, 2024

Psychiatry is getting more targeted as drugmakers develop a new range of treatments for depression.

317

317

STAT

NOVEMBER 11, 2024

AbbVie said Monday that its experimental treatment for schizophrenia failed to significantly help patients in two trials, a blow to the company, which got the drug through its recent $9 billion acquisition of Cerevel Therapeutics. In Phase 2 studies, patients on different doses of the drug, called emraclidine, did not experience significant improvements on a test called the Positive and Negative Syndrome Scale (PANSS) compared with the placebo group.

348

348

pharmaphorum

NOVEMBER 11, 2024

Discover an expert perspective on how artificial intelligence is transforming the drug submission and approval process in the pharmaceutical industry. Explore the evolving role of AI in drug development.

Drug Development 127

Drug Development 127

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

NOVEMBER 11, 2024

Last week’s election results may signal political winds sweeping attention away from diversity, equity, and inclusion, but new research papers again make the case that people in different socioeconomic groups have differing health outcomes of concern.

315

315

BioPharma Dive

NOVEMBER 11, 2024

Negative drug results cost AbbVie billions of dollars in market value and convinced analysts that Bristol Myers had placed a better bet in buying Karuna Therapeutics.

131

131

The Pharmacist

NOVEMBER 11, 2024

Respiratory syncytial virus (RSV) is circulating above baseline levels with particularly pronounced increases in those under five years old, surveillance figures show. Emergency department attendances for acute bronchiolitis have also increased nationally, NHS figures show. And the UK Health Security Agency has warned that norovirus activity in the last two weeks of October was 16% […] The post RSV and norovirus circulating at high levels for time of year appeared first on The Pharmacist.

Vaccines 114

Vaccines 114

FDA Law Blog: Biosimilars

NOVEMBER 11, 2024

By Deborah L. Livornese & JP Ellison — On November 8, 2024, FDA issued a proposed order to remove the oral decongestant ingredient phenylephrine (including both phenylephrine hydrochloride and phenylephrine bitartrate) (collectively, PE) from the OTC monograph on the basis of a lack of effectiveness. FDA also noted that it has concluded that no safety signal was identified for oral PE at doses permitted under the monograph.

Pharmacy Management 109

Pharmacy Management Dosage Documentation 109

The Pharmacist

NOVEMBER 11, 2024

England's chief pharmaceutical officer (CPhO) David Webb is 'optimistic' about community pharmacy given the new government's priorities for healthcare, he told the Royal Pharmaceutical Society (RPS) conference on Friday. ''I was quite pleased when the government started talking about the three strategic shifts. sickness to prevention, analogue to digital, acute to community and primary - […] The post CPhO 'optimistic' about opportunities for community pharmacy appeared first on T

Community Pharmacies 111

Community Pharmacies 111

pharmaphorum

NOVEMBER 11, 2024

Mass General Brigham researchers have developed an AI that can spot hidden cases of long COVID from electronic health records

126

126

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

BioPharma Dive

NOVEMBER 11, 2024

Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the brand name Aucatzyl.

115

115

Pharmaceutical Business Review

NOVEMBER 11, 2024

ALT-B4 will be used for developing the subcutaneous formulation ENHERTU. As per the agreement, Daiichi Sankyo will gain global rights to utilise Alteogen’s ALT-B4, a human recombinant hyaluronidase enzyme. Furthermore, Alteogen is entitled to receive an upfront payment and milestone payments upon the achievement of certain development, regulatory, and sales-based goals from Daiichi Sankyo.

Biosimilars 98

Biosimilars 98

Compounding Pharmacy of America

NOVEMBER 11, 2024

New supplements and nutraceuticals seem to appear on the market every day, and some of these substances gain popularity very quickly due to their benefits. It’s important to have a balanced diet that’s dense in nutrients and minerals, and many people take supplements to provide the nutrients their everyday diets lack. The post Anti-Aging Benefits of High Potency Resveratrol appeared first on The Compounding Pharmacy of America.

Compounding Pharmacies 98

Compounding Pharmacies Compounding 98

BioPharma Dive

NOVEMBER 11, 2024

After an investigation, the agency concluded that a case of muscle weakness in one of Novavax’s trials was actually ALS and unrelated to vaccination.

Vaccines 105

Vaccines 105

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

pharmaphorum

NOVEMBER 11, 2024

FDA starts review of Unicycive's drug for hyperphosphataemia in patients with chronic kidney disease on dialysis, aiming to improve on onerous phosphate binder therapy

96

96

Pharmaceutical Technology

NOVEMBER 11, 2024

Aucatzyl is the first CAR-T cell therapy approved by the FDA with no requirement for a risk evaluation mitigation strategy (REMS) programme.

105

105

pharmaphorum

NOVEMBER 11, 2024

AbbVie's $8.7bn play for Cerevel looks like a poor bet as its lead schizophrenia drug flunks two phase 2 trials, but which rival stands to benefit?

101

101

PharmaTech

NOVEMBER 11, 2024

The new Institute for Cell Therapy Discovery and Innovation will utilize expertise to develop cell therapies for cancer, autoimmune diseases, and infections.

96

96

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

pharmaphorum

NOVEMBER 11, 2024

Autolus gets its first product approval, an FDA green light for anti-CD19 CAR-T Aucatzyl for B-cell acute lymphoblastic leukaemia

103

103

Drug Patent Watch

NOVEMBER 11, 2024

Effective management of drug patent portfolios is crucial for pharmaceutical companies to maintain market exclusivity, protect revenue streams, and drive innovation. A robust patent strategy aligned with business goals is essential for maximizing value and staying competitive in the pharmaceutical landscape.

Pharmaceutical Companies 86

Pharmaceutical Companies Pharmaceutical Companies 86

Express Pharma

NOVEMBER 11, 2024

Purple Life Sciences, a company focused on harnessing natural ingredients for medical treatment, launched PSOCARE, a healing oil for psoriasis, at an event today. This product marks one of the initial offerings from the research-led organisation, developed to manage psoriasis symptoms, including red patches, dry and cracked skin, itching, burning, flaking, scaling, and plaque formation.

Compounding 95

Compounding 95

Pharma Times

NOVEMBER 11, 2024

First car t-cell therapy accepted for second-line treatment in Scotland

123

123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Technology

NOVEMBER 11, 2024

BostonGene is a winner in four categories in the 2024 Pharmaceutical Technology Excellence Awards.

105

105

Welltopia Pharmacy

NOVEMBER 11, 2024

Discover the best multivitamins and minerals that support daily health, energy, immune function, and overall wellness. In an ideal world, a balanced diet provides all the necessary nutrients. However, it’s often challenging to meet daily nutritional requirements due to various factors like dietary restrictions, lifestyle, and aging.

Immunity 75

Immunity Immunization 75

Pharmaceutical Technology

NOVEMBER 11, 2024

Moderna has received Health Canada's approval for its respiratory syncytial virus messenger ribonucleic acid (mRNA) vaccine mRESVIA, designed to prevent lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals aged 60 and over.

Vaccines 64

Vaccines 64

The Guardian - Pharmaceutical Industry

NOVEMBER 11, 2024

Experts say once-a-day varenicline tablet reduces nicotine cravings and side-effects from cutting out tobacco Hundreds of thousands of smokers will be given a pill that increases people’s chances of quitting, in a move that NHS bosses believe will save thousands of lives. About 85,000 people a year in England will be offered the chance to use varenicline, a once-a-day tablet that experts say is as effective as vapes at helping people to kick the habit.

69

69

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Pharma Times

NOVEMBER 11, 2024

New treatment option approved for women in Scotland

108

108

assurecare

NOVEMBER 11, 2024

Revolutionizing Healthcare: How AI is Driving Efficiency, Cost Savings, and Better Outcomes Artificial intelligence (AI) is no longer just a buzzword in healthcare—it’s a game changer. From enhancing member engagement to creating personalized care plans, AI has moved to the forefront of healthcare innovation. What started as an experimental technology in the 1980s is now a critical part of modern healthcare strategies, thanks to recent advancements in processing power and tools like ChatGPT.

59

59

Pharmafile

NOVEMBER 11, 2024

11 November 2024 AOTI, INC. (AIM: AOTI), a medical technology group focussed on the durable healing of wounds and prevention of amputations, is pleased to note that the Centers for Medicare and Medicaid Services (CMS), through its Durable Medical Equipment (DME) Medicare Administrative Contractors (MACs), has scheduled a public Contractor Advisory Committee (CAC) meeting.

59

59

BioPharma Dive

NOVEMBER 11, 2024

Shares in AbbVie slumped Monday after the company disclosed its psychiatric medicine emraclidine didn’t best placebo in two Phase 2 trials.

64

64

Pharmafile

NOVEMBER 11, 2024

Theramex, a dedicated women’s health company, have announced that the Scottish Medicines Consortium (SMC) have recommended YSELTY (linzagolix) for the treatment of moderate or severe symptoms of uterine fibroids (UFs) in adult women of reproductive age. The decision from the SMC will see YSELTY available on the NHS across Scotland. Dr Sigi Joseph, co-founder of The […] The post Theramex receives recommendation for YSELTY in Scotland appeared first on Pharmafile.

59

59